BOD — Bod Science Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Bod Science, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.524 | 2.51 | 0.899 | 1.52 | 1.53 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.48 | -3.23 | -5.83 | -4.18 | -5.68 |
| Capital Expenditures | -0.064 | -0.021 | -0.019 | -0.019 | -0.069 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.072 | -0.442 | -0.008 | -0.188 | -0.22 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.136 | -0.464 | -0.027 | -0.207 | -0.29 |
| Financing Cash Flow Items | -0.463 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.35 | 7.23 | 7.5 | 0 | 4.14 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.272 | 3.54 | 1.67 | -4.39 | -1.63 |